Does Rallies show 13F holders for RXST?

Yes. Rallies tracks hedge fund and 13F ownership data for RXST, including fund names, share counts, latest tracked quarter, and position changes when available.

Is RXST research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RXST. It does not provide personalized investment advice.

RXST (RxSight, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

RxSight, Inc. Common Stock (RXST) is a publicly traded Healthcare sector company. As of May 21, 2026, RXST trades at $6.17 with a market cap of $248.38M and a P/E ratio of -5.38. RXST moved +3.53% today. Year to date, RXST is -41.11%; over the trailing twelve months it is -62.94%. Its 52-week range spans $5.30 to $55.57. Analyst consensus is neutral with an average price target of $9.83. Rallies surfaces RXST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns RXST stock?

Hedge funds tracked by Rallies that own RXST include Exoduspoint Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for RxSight, Inc. Common Stock.

RXST Key Metrics

Key financial metrics for RXST
Metric	Value
Price	$6.17
Market Cap	$248.38M
P/E Ratio	-5.38
EPS	$-1.13
Dividend Yield	0.00%
52-Week High	$55.57
52-Week Low	$5.30
Volume	97
Avg Volume	0
Revenue (TTM)	$127.48M
Net Income	$-46.64M
Gross Margin	77.02%

Top Hedge Funds Holding RXST

Exoduspoint Capital holds 106.64K shares of RXST, changed +17.29% as of Mar 31, 2026.

Latest RXST News

RxSight Q1 Sales Fall 18.5% to $30.9M While Installed Base Tops 1,154 — May 6, 2026
RxSight Hits 300,000 Implants, Reports 93.1% 20/20 Clinical Outcomes — Apr 8, 2026
RxSight narrows Q4 loss to $0.03, posts $32.6M revenue beat — Feb 26, 2026
RxSight Expands Installed Base 20% After 12% Procedure Growth, Appoints New CFO — Jan 14, 2026

Recent RXST Insider Trades

Fountain Tamara sold 7.00K (~$180.00K) on Mar 12, 2025.
Maniar Shweta sold 3.52K (~$108.62K) on Jan 22, 2025.
Corley Jesse Anderson bought 1.77K (~$55.00K) on Jan 16, 2025.

RXST Analyst Consensus

9 analysts cover RXST: 0 strong buy, 1 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $9.83.

Common questions about RXST

Who owns RXST stock?: Hedge funds tracked by Rallies that own RXST include Exoduspoint Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for RxSight, Inc. Common Stock.
Does Rallies show 13F holders for RXST?: Yes. Rallies tracks hedge fund and 13F ownership data for RXST, including fund names, share counts, latest tracked quarter, and position changes when available.
Is RXST research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RXST. It does not provide personalized investment advice.